This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tang, P.
Right arrow Articles by Willey, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tang, P.
Right arrow Articles by Willey, B. M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, May 2004, p. 2282-2284, Vol. 42, No. 5
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.5.2282-2284.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Use of the Vitek-1 and Vitek-2 Systems for Detection of Constitutive and Inducible Macrolide Resistance in Group B Streptococci

Patrick Tang,1,2 Peter Ng,1 Ming Lum,1 Martin Skulnick,1 Glen W. Small,1 Donald E. Low,1,2 Alicia Sarabia,3 Tony Mazzulli,1,2 Katherine Wong,1 Andrew E. Simor,2,4 and Barbara M. Willey1*

Department of Microbiology, Toronto Medical Laboratories and Mount Sinai Hospital,1 University of Toronto,2 MDS Laboratories Inc.,3 Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada4

Received 30 November 2003/ Returned for modification 20 January 2004/ Accepted 10 February 2004

A prospective study of erythromycin and clindamycin resistance was performed with 304 consecutive group B streptococci (GBS) isolates. According to two automated susceptibility testing systems, Vitek-1 and Vitek-2, and double-disk agar diffusion, 79.9% were susceptible to both erythromycin and clindamycin. However, for macrolide-lincosamide-streptogramin B-inducible isolates, the accuracies of the Vitek-1 and Vitek-2 systems were 5.6 and 94.4%. In light of these results, we recommend that GBS be routinely tested using the double-disk diffusion method.


* Corresponding author. Mailing address: Department of Microbiology, Mount Sinai Hospital, Room 1460, 600 University Ave., Toronto, Ontario, Canada M5G 1X5. Phone: (416) 586-3121. Fax: (416) 586-3140. E-mail: bwilley{at}mtsinai.on.ca.


Journal of Clinical Microbiology, May 2004, p. 2282-2284, Vol. 42, No. 5
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.5.2282-2284.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Richter, S. S., Howard, W. J., Weinstein, M. P., Bruckner, D. A., Hindler, J. F., Saubolle, M., Doern, G. V. (2007). Multicenter Evaluation of the BD Phoenix Automated Microbiology System for Antimicrobial Susceptibility Testing of Streptococcus Species. J. Clin. Microbiol. 45: 2863-2871 [Abstract] [Full Text]  
  • Tazi, A., Reglier-Poupet, H., Raymond, J., Adam, J.-M., Trieu-Cuot, P., Poyart, C. (2007). Comparative evaluation of VITEK 2(R) for antimicrobial susceptibility testing of group B Streptococcus. J Antimicrob Chemother 59: 1109-1113 [Abstract] [Full Text]